BioAgilytix

In a recent article published in @ipimediaworld BioAgilytix CSO @JMcNally_BAL explores why bioanalysts should prepare for the impending wave of cell & gene therapies & the factors they must consider in their pre-existing immunogenicity assessments: bit.ly/40U21By

On International Day of Women & Girls in Science, we celebrate and honor the #WomenInScience at BioAgilytix for their contribution to research and innovation.

#thankyou #careershavenogender #WomenInStem

#ICYMI: Scientific Officer Amanda Hays, PhD, joined a @BioanalysisZone panel of experts to discuss the benefits and drawbacks of new modalities. Listen to their discussion on how advanced therapies are being implemented into the bioanalytical field. Watch: bit.ly/3wm6BKM

BioAgilytix is pleased to announce a new #partnership with @Microba Life Sciences, the industry leader in #microbiome analysis. The partnership enables both companies to fast-track the delivery of new therapeutics to patients >>bit.ly/3HxD5a7 #Partnerships #CRO

When a person has a cardiac arrest, survival depends on immediately receiving CPR from someone nearby.

On Wear Red Day, in honor of American Heart Month, we invite you to help your community by learning the 2 simple steps of Hands-Only #CPR >> bit.ly/3K2BFE5